Search Results - "Graseck, L."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Efficacy and tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC)

    Efficacy and tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC) by Binder, D., Hackenthal, M., Graseck, L., Schweisfurth, H., Schäper, C., Krüll, M., Temmesfeld-Wollbrück, B., Suttorp, N., Beinert, T., Hellriegel, K.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 18159 Background: Docetaxel-cisplatin, administered every 3 weeks, is an effective first-line chemotherapy for locally advanced or metastatic…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

    Tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment in patients with stage IIIB/IV non-small cell lung cancer (NSCLC) by Binder, D., Hackenthal, M., Graseck, L., Schweisfurth, H., Schäper, C., Temmesfeld-Wollbrück, B., Suttorp, N., Beinert, T., Hellriegel, K.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 17112 Background: Recent trials have shown that the combination docetaxel-cisplatin is an effective first-line treatment in locally advanced or…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: